Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs

NCT00675207 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Brimonidine purite 0.15%
DRUG: Dorzolamide 2%
DRUG: Brinzolamide 1%

Sponsor

Northwestern Ophthalmic Institute S.C.

Collaborators

[object Object]